Adriamycin and mitomycin C: possible synergistic cardiotoxicity.

No abstract is available for this paper.

• Publication year

  1978

• Venue

  Cancer treatment reports

• Publication date

  1978-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 688243
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Time relationship between last dose of daunorubicin and congestive heart failure.

  1977cited by this paper
• Adriamycin cardiomyopathy—risk factors

  1977cited by this paper
• High incidence of cardiomyopathy in children treated with adriamycin and DTIC in combination chemotherapy.

  1977cited by this paper
• Cardiotoxicity of adriamycin and related anthracyclines.

  1976cited by this paper
• Adriamycin and radiation: synegistic cardiotoxicity.

  1975cited by this paper
• Cardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin‐D and mithramycin

  1975cited by this paper
• Cardiac and pulmonary effects of high doses of cyclophosphamide and isophosphamide.

  1974cited by this paper

• Understanding the Mechanisms of Chemotherapy-Related Cardiotoxicity Employing hiPSC-Derived Cardiomyocyte Models for Drug Screening and the Identification of Genetic and Epigenetic Variants

  2025cites this paper
• Cardiovascular Toxicities of Chemotherapy

  2020cites this paper
• Safety and Efficacy of s-MOX Regimen in Patients with Colorectal Cancer Who Developed Cardiotoxicity Following Fluoropyrimidine Administration: A Case Series

  2020cites this paper
• Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics

  2019influential citation
• The role of antioxidants in the era of cardio-oncology

  2013cites this paper
• Targeted Prodrugs of a Novel Platform Anthracycline: Doxazolidine

  2012cites this paper
• Cardiotoxicidad por quimioterapia. Un enfoque práctico para el clínico

  2011cites this paper
• Drug-induced heart failure.

  2011cites this paper
• Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs

  2006cites this paper
• Cardiotoxicity induced by chemotherapy and antibody therapy.

  2006cites this paper
• Cardiotoxicity of cancer therapy.

  2005cites this paper
• Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.

  2004cites this paper
• Antitumor chemotherapy after fluorouracil angina

  2004cites this paper
• Insuffisances cardiaques d’origine médicamenteuse (en dehors des anthracyclines)

  2004cites this paper
• Mitomycin C-induced organ toxicity in Wistar rats: a study with special focus on the kidney

  2004cites this paper
• Cardiotoxicity of mitomycin A, mitomycin C, and sevenN7 analogs in vitro

  2004influential citation
• [Drug-induced heart failure (excluding that caused by anthracyclines)].

  2004cites this paper
• Mitomycin C‐Induced Renal Insufficiency: A Case Report

  2003cites this paper
• Chemotherapy‐induced cardiotoxicity: current practice and prospects of prophylaxis

  2002cites this paper
• Cardiotoxicity of Chemotherapeutic Agents

  2000cites this paper
• Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

  2000cites this paper
• The effects of mitomycin-C and temperature on dynamical properties of human erythrocyte membrane.

  1997cites this paper
• A prospective study of pulmonary function in patients receiving mitomycin.

  1996cites this paper
• Metabolic Effects of Chemotherapy on the Heart

  1993cites this paper
• Contrasting molecular cytotoxic mechanisms of mitomycin C and its two analogs, BMY 25282 and BMY 25067, in isolated rat hepatocytes.

  1993cites this paper
• SEVERE ADRIAMYCIN CARDIOTOXICITY AT CUMULATIVE DOSE BELOW 500 MG/M2: CASE REPORT AND REVIEW OF THE LITERATURE

  1992cites this paper
• Pediatric Neoplastic Disorders

  1992cites this paper
• The cardiotoxicity of chemotherapeutic drugs.

  1992cites this paper
• Right heart failure after chemotherapy.

  1991cites this paper
• Phase I trial of FK973: Description of a delayed vascular leak syndrome

  1991cites this paper
• Diminishment of Respiratory Sinus Arrhythmia Foreshadows Doxorubicin‐Induced Cardiomyopathy

  1991cites this paper
• Long-Term Complications of Antineoplastic Agents

  1991cites this paper
• Cardiopulmonary complications of mitomycin‐C

  1990cites this paper
• Other Antitumor Antibiotics

  1989cites this paper
• Mitomycin C adjuvant chemotherapy after Wertheim's hysterectomy for stage IB cervical cancer

  1989cites this paper
• Free-radical formation by mitomycin C and its novel analogs in cardiac microsomes and the perfused rat heart.

  1989cites this paper
• Cardiac, Renal, and Pulmonary Toxicity of Several Mitomycin Derivatives in Rats

  1989cites this paper
• Cardiac, renal, and pulmonary toxicity of several mitomycin derivatives in rats.

  1989cites this paper
• New findings in the pharmacokinetic, metabolic, and drug-resistance aspects of mitomycin C.

  1988cites this paper
• Radionuclide angiographic monitoring in patients treated with potentially cardiotoxic cytostatic drugs.

  1988cites this paper
• [Cardiotoxic effect of adriamycin].

  1988cites this paper
• Radionuclide angiographic patients treated with potentially cytostatic drugs

  1988cites this paper
• Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy.

  1988cites this paper
• A prospective study on the dose dependency of cardiotoxicity induced by mitomycin C

  1988cites this paper
• Mitomycin C is an inactive drug in the third-line treatment of hormone and chemotherapy refractory breast cancer.

  1987cites this paper
• Cardiotoxicity during Chemotherapy for Advanced Gastroenteric Tumors

  1987cites this paper
• Mitomycin C-induced hemolytic uremic syndrome. Six case reports and review of the literature on renal, pulmonary and cardiac side effects of the drug.

  1987cites this paper
• [Toxic drug-induced myocardial diseases].

  1987cites this paper
• Severe side effects of the cytotoxic drug mitomycin-C.

  1987cites this paper
• Pharmacokinetics of mitomycin-C in plasma and tumor tissue of cervical cancer patients and in selected tissues of female rats.

  1986cites this paper
• A comparative study of bisantrene given by two dose schedules in patients with metastatic breast cancer

  1986cites this paper
• Doxorubicin versus mitomycin versus doxorubicin plus mitomycin in advanced breast cancer: a randomized study.

  1986cites this paper
• Concomitant illness in patients treated for Hodgkin's disease.

  1986cites this paper
• Mitomycin-C in breast cancer.

  1985cites this paper
• Mitomycin in metastatic breast cancer refractory to hormonal and combination chemotherapy

  1985cites this paper
• Doxorubicin‐induced congestive heart failure in adults

  1985cites this paper
• A review of mitomycin regimens in advanced breast cancer therapy.

  1985cites this paper
• Gastric cancer: complete chemotherapy response in an elderly woman: current status of treatment.

  1985cites this paper
• Early and delayed clinical cardiotoxicity of doxorubicin

  1985cites this paper
• Possible enhancement of the cardiotoxicity of doxorubicin when combined with mitomycin C

  1985cites this paper
• Mitomycin: ten years after approval for marketing.

  1985cites this paper
• Nephrotoxicities of antineoplastic and immunosuppressive agents.

  1984cites this paper
• Combination chemotherapy with doxorubicin and mitomycin C in non small cell bronchogenic carcinoma: Severe pulmonary toxicity from q 3 weekly mitomycin C

  1984cites this paper
• Recovery from mitomycin C‐induced hemolytic uremic syndrome: A case report

  1984cites this paper
• Mitomycin‐C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second‐line regimen in lung cancer

  1984cites this paper
• [Cardiotoxicity of anthracyclines].

  1984cites this paper
• Detection of antineoplastic agent induced cardiotoxicity by 31P NMR of perfused rat hearts.

  1983cites this paper
• Doxorubicin (adriamycin) cardiomyopathy.

  1983cites this paper
• Renal disease associated with mitomycin therapy.

  1983cites this paper
• Human myocardial histologic characteristics in congestive heart failure.

  1983cites this paper
• An effective low‐dose mitomycin regimen for hormonal‐ and chemotherapy‐refractory patients with metastatic breast cancer

  1983cites this paper
• The Quarterly Case Renal Disease Associated with Mitomycin Therapy

  1983cites this paper
• Mitomycin C combination therapy against murine tumor systems: Effectiveness with cyclophosphamide and methotrexate

  1983cites this paper
• Interaction between Doxorubicin and Mitomycin C on Mortality and Myocardial Contractility in Guinea PIG

  1983cites this paper
• Mitomycin C: interstitial pneumonitis and haemolytic-uraemic syndrome.

  1983cites this paper
• Noninvasive cardiac evaluation of patients receiving adriamycin‐containing adjuvant chemotherapy (FAC) for stage II or III breast cancer

  1983cites this paper
• The cardiotoxicity of anticancer agents.

  1982cites this paper
• Doxorubicin cardiotoxicity.

  1982cites this paper
• [Complications of antitumor and antileukemia chemotherapy. 3 (conclusion)].

  1982cites this paper
• Veno‐occlusive disease of the liver after high‐dose mitomycin C therapy and autologous bone marrow transplantation

  1982cites this paper
• Mitomycin C-enhanced superoxide and hydrogen peroxide formation in rat heart.

  1981cites this paper
• Doxorubicin and dactinomycin therapy for advanced sarcomas.

  1981cites this paper
• Renal disease after mitomycin c therapy

  1981cites this paper
• Zinostatin and doxorubicin. A combination phase I study.

  1981cites this paper
• [Cardiac complications of chemotherapy and radiotherapy].

  1981cites this paper
• Mitomycin C in Metastatic Breast Cancer Resistant to Hormone Therapy and Conventional Chemotherapy

  1980cites this paper
• Cardiac toxicity from antitumor therapy.

  1980cites this paper
• Pulmonary toxicity of mitomycin

  1980cites this paper
• Cardiotoxicity of mitomycin C in man and animals.

  1979cites this paper
• Adriamycin cardiotoxicity: a survey of 1273 patients.

  1979cites this paper
• Cytostatic and immunosuppressive drugs

  1979cites this paper
• Drug-associated cardiotoxicity.

  1979cites this paper
• Risk factors for doxorubicin-induced congestive heart failure.

  1979cites this paper